Lim et al. [25] found that when SREBPs (sterol-regulator-element-binding proteins) were lost in regulatory T cells, the proportion of CD4 and CD8 T cells in TME increased, tumor growth was inhibited, and the efficacy of anti-PD1 therapy was enhanced. This evidence concerns the gene CD4 and neoplasm.